<DOC>
	<DOCNO>NCT02742532</DOCNO>
	<brief_summary>The purpose study determine whether oxytocin decrease crave use alcohol stress reactivity follow exposure laboratory-induced stress among Active Duty Service Members dual diagnosis alcohol use disorder post-traumatic anxiety .</brief_summary>
	<brief_title>Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress</brief_title>
	<detailed_description>The purpose study determine whether intra-nasally administer oxytocin decrease crave use alcohol stress reactivity follow exposure laboratory-induced stress among Active Duty Service Members ( AD SMs ) dual diagnosis alcohol use disorder post-traumatic anxiety ( i.e. , PTSD anxiety disorder NOS ) . This 2-arm placebo control study . Subjects complete battery self-report questionnaires behavioral interview . Baseline assessment subjective ( crave , stress ) , physiologic ( HR , BP ) , neuroendocrine measure ( salivary cortisol ) collect . These assessment repeatedly collect throughout test portion study . Subjects receive acute administration intra-nasal oxytocin placebo expose laboratory-induced social stressor . They ask give short speech perform arithmetic front panel judge . Following task , additional post-task assessment subjective , physiological , neuroendocrine measure complete next hour .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Active Duty Service Members , service branch ; age 1865 year . Meets clinician assessment current PTSD OR anxiety disorder NOS OR score DASS &gt; 10 Anxiety &gt; 19 Stress . Meets clinician assessment alcohol use disorder ( AUD ) OR score &gt; 8 AUDIT . If meet current lifetime criterion another substance disorder , must indicate AUD primary . Subjects take psychotropic medication require maintain stable dose least two week study initiation ( unless physician 's discretion follow psychological consult ) . Negative urine drug screen test BAC =0 . Able comprehend English . Able provide inform consent function intellectual level sufficient allow completion assessment instrument . Must consent random assignment oxytocin placebo . Positive urine drug screen ( except marijuana ) BAC &gt; 0 . Untreated subject currently symptomatic psychotic bipolar affective disorder . Subjects current suicidal homicidal ideation intent , would present serious suicide risk . Subjects psychotropic drug initiate past 2 week ( unless approve physician 's discretion follow psychological consult ) . Subjects history major medical illness ( e.g. , endocrine , cardiovascular , central nervous system disorder , peripheral neuropathy , pulmonary disease ) acute unstable medical condition might interfere safe conduct study accurate interpretation result . Subjects experience withdrawal symptom report Clinician systolic BP≥160 mmHg , diastolic BP ≥100 mmHg rest HR ≥100 bpm . Subject consider unsuitable study opinion study PI AIs reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>